Drug details
Votrient (pazopanib tablets)
type of Antineoplastic Tyrosine Kinase Inhibitors, Antineoplastics, VEGF Inhibitor
Votrient (pazopanib) is a tyrosine kinase inhibitor used to treat kidney cancer, and it may also be used to treat certain other types of cancer (soft tissue sarcoma).
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- fever,
- confusion,
- body aches,
- chest pain,
- vision problems,
- pain spreading to your jaw or shoulder,
- seizure,
- severe headache,
- blurred vision,
- headache,
- wheezing,
- cough,
- fainting,
- sweating,
- chest pain or pressure,
- sore throat,
- flu symptoms,
- sudden numbness or weakness,
- slurred speech,
- bloody or tarry stools,
- coughing up blood,
- vomit that looks like coffee grounds,
- fast or pounding heartbeats,
- pain or burning when you urinate,
- skin sores,
- sudden chest pain or discomfort,
- dry cough,
- anxiety
- pounding in your neck or ears, and
- headache with chest pain and severe dizziness,
- swelling or rapid weight gain,
- vision loss,
- sudden shortness of breath,
- any wound that will not heal,
- feeling short of breath,
- change in mental status,
- unusual bleeding or bruising,
- slow healing of a wound or surgical incision,
- pain or cold feeling in an arm or leg,
The following drugs are related to Votrient, either as a replacement or used together:
- Proleukin (aldesleukin for injection)
- Aranesp (darbepoetin alfa)
- Cabometyx (cabozantinib tablets)
- Epogen (epoetin alfa)
- Fotivda (tivozanib capsules)